Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

By | August 17, 2021
A study, available on the pre-print server bioRxiv*, evaluated the neutralizing capacity of a fully human polyclonal antibody (SAB-185) against the Delta, Kappa, and Lambda variants using a lentiviral-based pseudovirus assay.